U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07920367) titled 'Non-Invasive Biomarker Monitoring in UC on Biologics' on Oct. 30.
Brief Summary: Ulcerative colitis (UC) is a long-term inflammatory bowel condition. Many patients are treated with intravenous biologic drugs such as infliximab or vedolizumab. Measuring the level of these drugs in the blood helps doctors adjust treatment, but results can take one to two weeks to come back.
Volatile organic compounds (VOCs) are gases released from stool and urine that reflect activity in the gut, including gut bacteria and inflammation. They can be measured quickly and without needles.
This study will find out whether VOCs in stool and urine can tell...